Americans Are Spending Billions on Drugs That Don’t Work
Companies are increasingly using fast-track approval processes to get unproven treatments to patients.
Companies are increasingly using fast-track approval processes to get unproven treatments to patients.
The Living Rare, Living Stronger NORD Patient and Family Forum will be a truly patient first event. Through it all, we will maintain our objectives:…
This very special event will celebrate NORD’s legacy and achievements, and honor those individuals and organizations doing remarkable work on behalf of the rare disease…
Researchers are using computer and AI technologies to create a Caregiving Robot Assistant (CART) for ALS patients and their caregivers.
An estimated 5.4 million children help care for relatives, as families can’t afford or find other in-home care.
Doris Hansen, MD, discusses the treatment of multiple myeloma using D-Rd and V-Rd in transplant-ineligible patients.
The agency seeks feedback at a 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special…
The Isabel Zendal Nursing Hospital in the Community of Madrid is now home to a specialized Day…
A big boost is coming to local ALS research in the form of $13.5 million gift to the University of Cincinnati’s Gardner Neuroscience Institute.
The administration should expand, not restrict, the program.